Category: Pharma & drug development
The rise of gout: examining drug development for an age-old disease
Catching cancer: could a new blood test rewrite oncology?
Oxytocin: the therapeutic potential of the ‘love hormone’
Crabby concoctions: Why pharma’s thirst for crustacean blood is up for debate
How a new crystallography technique may speed up drug development
How research groups are tackling the problem of biologics drug delivery
Intellectual property in the time of COVID-19
Could nanoparticles unlock the pharmaceutical benefits of turmeric?
Finding a cure for HIV with ViiV Healthcare
Peptomyc: the quest for a universal cancer treatment
What does ‘ageing’ mean when it comes to drug development?
Sky high: should US drugs prices fall in line with the rest of the world?
The rise of fake medicines in Africa
Q&A: Gavi alliance talks immunising 300 million people
Recurrent miscarriage: could this devastating condition have a simple cure?
A safer ride: the latest innovation in targeted cancer treatment
The problem of manipulated data
Why is pharma so bad at sharing clinical trial information?
